Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
-25.13%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$97.5B
AUM Growth
-$45.1B
Cap. Flow
-$1.29B
Cap. Flow %
-1.32%
Top 10 Hldgs %
35.7%
Holding
526
New
28
Increased
112
Reduced
187
Closed
33

Sector Composition

1 Consumer Discretionary 27.47%
2 Healthcare 25.5%
3 Technology 17.5%
4 Communication Services 10.66%
5 Financials 6.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SILK
426
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$9K ﹤0.01%
235
SRNE
427
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$9K ﹤0.01%
4,314
ACAD icon
428
Acadia Pharmaceuticals
ACAD
$4.3B
$8K ﹤0.01%
544
CERS icon
429
Cerus
CERS
$255M
$8K ﹤0.01%
1,459
+316
+28% +$1.73K
LBRDK icon
430
Liberty Broadband Class C
LBRDK
$8.53B
$8K ﹤0.01%
70
NTNX icon
431
Nutanix
NTNX
$18.4B
$8K ﹤0.01%
563
PLL
432
DELISTED
Piedmont Lithium
PLL
$8K ﹤0.01%
212
ATEX icon
433
Anterix
ATEX
$417M
$7K ﹤0.01%
162
BMRN icon
434
BioMarin Pharmaceuticals
BMRN
$10.9B
$7K ﹤0.01%
82
COLM icon
435
Columbia Sportswear
COLM
$3.15B
$7K ﹤0.01%
95
HI icon
436
Hillenbrand
HI
$1.82B
$7K ﹤0.01%
170
LSPD icon
437
Lightspeed Commerce
LSPD
$1.6B
$7K ﹤0.01%
310
MATV icon
438
Mativ Holdings
MATV
$659M
$7K ﹤0.01%
265
NVAX icon
439
Novavax
NVAX
$1.27B
$7K ﹤0.01%
130
RARE icon
440
Ultragenyx Pharmaceutical
RARE
$3.01B
$7K ﹤0.01%
115
VUZI icon
441
Vuzix
VUZI
$171M
$7K ﹤0.01%
924
WSM icon
442
Williams-Sonoma
WSM
$24.7B
$7K ﹤0.01%
126
NVRO
443
DELISTED
NEVRO CORP.
NVRO
$7K ﹤0.01%
154
FOLD icon
444
Amicus Therapeutics
FOLD
$2.47B
$6K ﹤0.01%
538
BLNK icon
445
Blink Charging
BLNK
$117M
$5K ﹤0.01%
327
-73
-18% -$1.12K
CSTL icon
446
Castle Biosciences
CSTL
$670M
$5K ﹤0.01%
225
CVGW icon
447
Calavo Growers
CVGW
$486M
$5K ﹤0.01%
113
FGEN icon
448
FibroGen
FGEN
$45.7M
$5K ﹤0.01%
19
LASR icon
449
nLIGHT
LASR
$1.47B
$5K ﹤0.01%
468
MASS icon
450
908 Devices
MASS
$198M
$5K ﹤0.01%
249